Compounded tirzepatide through TrimRx costs $349 monthly, still more expensive than compounded semaglutide but significantly less than brand options
This helps with long-term adherence and metabolic adaptations
Under this perspective, as reported in a systematic analysis for the Global Burden of Disease Study 2021 [1, 2], the age-standardized rates of deaths per 100,000 individuals attributed to 37 unique conditions affecting the nervous system that now include neurodevelopmental disorders, late-life neurodegeneration, and emergent conditions such as cognitive impairment following coronavirus disease 2019 (COVID-19), has decreased by 33.6% from 1990 to 2021
The data in Table 1 reflect the exposure of 2,327 patients with type 1 diabetes to insulin glargine or NPH in Studies A, B, C, and D [see Clinical Studies (14.2)]
Key highlights Semaglutide loses its safety and efficacy after expiration
Simoni M, Brigante G, Rochira V, Santi D, Casarini L